Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935800 · ClinicalTrials.gov registry record
The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates
A clinical trial, sponsored by Methodist Health System.
- Active
- Registry status
- 208
- Enrollment target
NCT05935800 is a clinical trial that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 208 participants.
The verdict
NCT05935800 is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 208 participants
- Enrollment target
Study Summary
Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decreased patient strength and vitality.
Interventions
- BEHAVIORAL COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2022-04-19 |
| Est. Completion | 2028-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05935800
The ClinicalTrials.gov registry entry for NCT05935800 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC is the first listed.
NCT05935800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05935800 about?
NCT05935800 is a clinical study titled "The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates". Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decrease...
What is the current status of trial NCT05935800?
This trial is currently active not recruiting. The enrollment target is 208 participants. The study started on 2022-04-19. Estimated completion is 2028-04-19.
What interventions are being tested in trial NCT05935800?
The interventions under investigation include: COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC (BEHAVIORAL).
Who is sponsoring clinical trial NCT05935800?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.